Reuters logo
Thermo Fisher did not infringe genetic-testing patent, U.S. top court says
February 22, 2017 / 3:14 PM / 7 months ago

Thermo Fisher did not infringe genetic-testing patent, U.S. top court says

Feb 22 (Reuters) - The U.S. Supreme Court on Wednesday cleared a subsidiary of biotech company Thermo Fisher Scientific Inc of infringing a genetic-testing kit patent held by Promega Corp, overturning a lower court’s decision.

The justices decided 8-0 that the subsidiary, Life Technologies Corp, could not be held liable for violating the patent by shipping one part of a testing kit from the United States to Britain, where it was assembled with other parts and sold overseas.

Reporting by Andrew Chung; Editing by Will Dunham

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below